March 16, 2010 – Preliminary results from the single-center study suggest that compared to SPECT myocardial perfusion ...
March 9, 2010 – As an alternative to the technetium (Tc-99M) isotope used in many nuclear imaging studies, UltraSPECT is ...
March 8, 2010 – A new U.S. source for the positron emission tomography (PET) agent F18 sodium fluoride is now offered ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
February 17, 2010 — An agreement has been reached to further augment and diversify a manufacturer's supply of molybdenum ...
January 26, 2010 – The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) selected GE Hitachi ...
January 25, 2010 - Heart failure is a serious medical condition, in which the heart muscle progressively loses its ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
December 18, 2009 - The U.S. radiopharmacy network currently owned by Covidien is being sold to Triad Isotopes in a deal ...
December 15, 2009 - The New FDA guidelines on current good manufacturing practices (cGMPs) for the production of ...
December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam technology as a ...
November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the ...
November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease ...
November 6, 2009 - As the American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for approval ...
November 4, 2009 - The Centers for Medicare and Medicaid Services (CMS) released the review copy of the 2010 Hospital ...
November 2, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions, announced it is a ...
October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized medicine, in ...
October 20, 2009 - 2-18F-fluoropropionic acid (18F-FPA) as a PET tracer for imaging prostate cancer has potential for ...
October 8, 2009 - Bayer Schering Pharma AG, Germany, will provide its development candidate florbetaben, a PET (positron ...
September 23, 2009 - The results of the Phase 0 (exploratory), or “first-in-human,” study indicated that the bio ...
September 21, 2009 - GE Healthcare hosts two consortium workshops on imaging technologies and molecular imaging agents ...
September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd., a ...